Centre Hospitalier Régional Metz-Thionville

chr-metz-thionville.fr

Total trials

117

Active

19

Phase 3

1

Total enrollment

4,311,630

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 3 of 3 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
Glucose 30% Intravenous Solution1
Epidural analgesia1
Bilateral rectus sheath block1

Next readouts

  • 2027-03-28
  • 2028-10-10

Top conditions

  • Cataract7
  • Keratoconus3
  • Burns2
  • Emergencies2
  • End Stage Chronic Renal Failure2
  • Osteoporosis2
  • Cardiac Arrest2
  • Fuchs' Endothelial Corneal Dystrophy2

Frequently asked questions about Centre Hospitalier Régional Metz-Thionville

How many clinical trials does Centre Hospitalier Régional Metz-Thionville have on ClinicalTrials.gov?
Centre Hospitalier Régional Metz-Thionville is listed as the lead sponsor on 117 clinical trials in ClinicalTrials.gov, 19 of which are currently active (recruiting, enrolling, or ongoing).
How many of Centre Hospitalier Régional Metz-Thionville's trials are in Phase 3?
1 of Centre Hospitalier Régional Metz-Thionville's trials are in Phase 3, spread across 3 active drug programs.
What therapeutic areas does Centre Hospitalier Régional Metz-Thionville focus on?
Centre Hospitalier Régional Metz-Thionville's most-studied conditions on ClinicalTrials.gov are Cataract, Keratoconus, Burns, Emergencies, End Stage Chronic Renal Failure.
When are Centre Hospitalier Régional Metz-Thionville's next clinical trial readouts?
Centre Hospitalier Régional Metz-Thionville has 2 upcoming primary-completion readouts tracked here; the soonest is “Evolution of the Initial Distribution Volume of Glucose in the Severe Burned Adults”, expected around 2027-03-28.